Company Stealth BioTherapeutics Corp
Equities
MITO
US85789A1051
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 14-12-31 | |
Martin Redmon
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
James R. Carr
CTO | Chief Tech/Sci/R&D Officer | 61 | 14-03-16 |
Janhavi Mohite
IRC | Investor Relations Contact | - | - |
Anthony Walsh
PRN | Corporate Officer/Principal | - | 21-12-31 |
Mike Malynn
HRO | Human Resources Officer | - | - |
Brian Hotchkiss
PRN | Corporate Officer/Principal | - | - |
Brian Blakey
PRN | Corporate Officer/Principal | 61 | 14-01-31 |
Henry H. Hess
LAW | General Counsel | 51 | 11-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 20-12-03 | |
Louis Lange
BRD | Director/Board Member | 72 | 19-07-23 |
Kevin McLaughlin
BRD | Director/Board Member | 67 | 17-03-13 |
Edward Owens
BRD | Director/Board Member | 77 | 17-05-23 |
Francis Chen
BRD | Director/Board Member | 75 | 06-04-19 |
Lok Chung Chan
CHM | Chairman | 73 | 07-10-21 |
Chief Executive Officer | 59 | 14-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,261,322 | 28,068,000 ( 3.913 %) | 0 | 3.913 % |
Company contact information
Stealth BioTherapeutics Corp.
140 Kendrick Street Buidling C-West
024494, Needham
+
http://www.stealthbt.comSector
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |